Ultra-High Pressure Balloon Catheter Market To Reach $775.7 Million By 2030

Ultra-High Pressure Balloon Catheter Market Growth & Trends

The global ultra-high pressure balloon catheter market size is anticipated to reach USD 775.7 million by 2030 and is anticipated to grow at a CAGR of 9.42% during the forecast period, according to a new report by Grand View Research, Inc. The ultra-high pressure balloon catheter industry is experiencing significant growth due to rising prevalence of cardiovascular diseases, including coronary artery disease and peripheral arterial disease and growing adoption of minimally invasive procedures. For instance, the World Health Organization (WHO) reported that cardiovascular diseases are the primary cause of death worldwide, claiming approximately 17.9 million lives annually. In 2022, around 702,880 people died from heart disease in the U.S. which is equivalent of one in every five deaths. In addition, coronary heart disease is the most common type of heart disease. In 2022, around 371,506 died with coronary heart disease in the U.S.

With an aging population and increased lifestyle-related risk factors, the need for effective interventional cardiology solutions has surged. Moreover, increased healthcare expenditures and investments in medical technologies by hospitals and clinics are fostering market growth. Support from regulatory authorities, such as recent FDA and marketing approvals for new devices, enhances market accessibility and adoption. For instance, in March 2022, SIS Medical AG (Swiss Interventional Systems), one of the global manufacturers in interventional cardiology, announced the U.S. Food & Drug Administration's approval of its lead product, the OPN NC Super High Pressure PTCA Balloon Catheter.

One of the most notable advancements in the ultra-high pressure balloon catheter industry is the development of new materials and designs that improve the mechanical properties of the catheters. Manufacturers are investing in research and development to create ultra-thin, high-strength materials that can withstand higher pressures while maintaining a smaller profile. For instance, advancements in polymer technology have led to the creation of balloons that can expand significantly at high pressures without rupturing. This enables more effective dilatation of narrowed vessels, thereby improving the success rates of procedures. Manufacturers are increasingly offering a range of balloon sizes, shapes, and lengths that can cater to individual patient anatomies and specific clinical scenarios. This customization ensures that healthcare providers have the right tools at their disposal to address varying medical needs, promoting better procedural effectiveness and patient safety.

 Request a free sample copy or view report summary: Ultra-High Pressure Balloon Catheter Market Report

Ultra-High Pressure Balloon Catheter Market Report Highlights

• Based on use, the therapeutic segment dominated the industry with the largest revenue share owing to the increasing prevalence of chronic diseases such as cardiovascular diseases, coupled with an aging population.

• Based on material, the nylon segment dominated the market with the largest revenue share as nylon is known for its high tensile strength, flexibility, and durability, making it an ideal choice for development of ultra-high pressure balloon catheters.

• Based on application, the nephrology segment is expected to witness significant growth during the forecast period owing to the rise in the prevalence of chronic kidney diseases (CKD) and end-stage renal disease (ESRD), often resulting from conditions such as diabetes and hypertension, necessitating enhanced treatment options.

• Based on end use, the hospitals dominated the industry with the largest revenue share owing to increasing number of surgical procedures, advancements in technology, a growing preference for minimally invasive interventions, and improved patient care standards.

• North America dominated the ultra-high pressure balloon catheter industry with a share of 40.21% in 2024. This can be attributed to the combination of factors including the presence of key manufacturers, increasing prevalence of cardiovascular diseases, technological advancements, a robust healthcare infrastructure, and a growing preference for minimally invasive procedures.

• Market players operating in ultra-high pressure balloon catheters market include Boston Scientific Corporation; BD; BrosMed Medical Co., Ltd; Terumo Medical Corporation; SIS Medical AG; Merit Medical Systems; TT Medical, Zhejiang Barty Medical Technology Co., Ltd.

Ultra-High Pressure Balloon Catheter Market Segmentation

Grand View Research has segmented the global ultra-high pressure balloon catheter market based on application, end use, and region:

Ultra-High Pressure Balloon Catheter Use Outlook (Revenue, USD Million, 2018 - 2030)

• Diagnostic

• Therapeutic

Ultra-High Pressure Balloon Catheter Material Outlook (Revenue, USD Million, 2018 - 2030)

• Nylon

• Polyester

Ultra-High Pressure Balloon Catheter Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cardiology

• Urology

• Nephrology

• Others

Ultra-High Pressure Balloon Catheter End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Ambulatory Surgical Centers (ASCs)

• Specialty Clinics

• Others

Ultra-High Pressure Balloon Catheter Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Ultra-High Pressure Balloon Catheter Market

• Boston Scientific Corporation

• BD

• BrosMed Medical Co., Ltd

• Terumo Medical Corporation

• SIS Medical AG

• Merit Medical Systems

• TT Medical

• Zhejiang Barty Medical Technology Co., Ltd